Rahul Mohindar, Director of viratechindia.com is of the view that, in midcap space, Glenmark Pharma has fairly good potential. The stock is expected to rally to Rs 490.
first published: Nov 22, 2012 02:40 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell

Live: Can Nifty claim new lifetime highs in December series? | Opening Bell

Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell

Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
You are already a Moneycontrol Pro user.

